Clinical trials
Completed Phase 2/3 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 4 |
| Catalysis SL | 2 |
| Chonbuk National University Hospital | 1 |
| Edgard Costa de Vilhena | 1 |
| Joslin Diabetes Center | 1 |
| Lund University | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| National Nutrition and Food Technology Institute | 1 |
| Oregon State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 22 |
| Obesity | 14 |
| Weight Loss | 4 |
| Inflammation | 3 |
| Metabolic Syndrome | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Insulin Resistance | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.